These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3627783)

  • 1. [The course of hypertrophic cardiomyopathy with outflow obstruction in patients under treatment].
    Cserhalmi L; Szabóki F; Csukás I; Ilovszky Z; Huszár G
    Orv Hetil; 1987 Aug; 128(35):1815-23. PubMed ID: 3627783
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic observations in idiopathic hypertrophic subaortic stenosis.
    Tajik AJ; Giuliani ER
    Mayo Clin Proc; 1974 Feb; 49(2):89-97. PubMed ID: 4855874
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.
    Swanton RH; Brooksby IA; Jenkins BS; Webb-Peploe MM
    Eur J Cardiol; 1977 Jun; 5(4):327-41. PubMed ID: 196858
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy.
    Minakata K; Dearani JA; Schaff HV; O'Leary PW; Ommen SR; Danielson GK
    Ann Thorac Surg; 2005 Sep; 80(3):851-6. PubMed ID: 16122442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Marked right ventricular outflow obstruction in two children with hypertrophic cardiomyopathy].
    Matsunaga S; Rikitake N; Yoshioka F; Kato H
    J Cardiogr; 1985 Sep; 15(3):931-9. PubMed ID: 3837078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evolution of the surgical strategy in hypertrophic cardiomyopathy: case studies of eight patients].
    Joudinaud T; Flecher E; Hvass U
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):16-21. PubMed ID: 18054343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Echocardiographic diagnosis of hypertrophic subaortic stenosis].
    Pennestrì F; Tanzi P; Boccardi L; Rulli FG
    Minerva Cardioangiol; 1980; 28(7-8):513-20. PubMed ID: 7192836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholization of the interventricular septum (Sigwart procedure) for treatment of hypertrophic cardiomyopathy.
    Di Mario C; Musso P; Moses JJ; Tucci G; Reimers B; Colombo A
    G Ital Cardiol; 1998 Jan; 28(1):45-9; discussion 50-2. PubMed ID: 9493045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
    Koga Y; Akiyoski T; Nagae K; Mizobuchi H; Toshima H
    Kokyu To Junkan; 1978 May; 26(5):473-6. PubMed ID: 351757
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of systolic anterior motion and left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy].
    Hasegawa I; Sakamoto T; Hada Y; Amano K; Yamaguchi T; Takenaka K; Takahashi H; Takikawa R; Takahashi T; Sugimoto T
    J Cardiogr; 1985 Sep; 15(3):655-67. PubMed ID: 3837060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with the treatment of patients with hypertrophic cardiomyopathy with obsidan and isoptin].
    Kisliak OA; Storozhakov GI
    Kardiologiia; 1984 Aug; 24(8):27-30. PubMed ID: 6238196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diastolic function and dynamics of the interventricular septum and lateral wall in patients with hypertrophic obstructive cardiomyopathy].
    Szabóki F; Cserhalmi L; Märcz I; Wessely M; Vajda G
    Orv Hetil; 1988 Jun; 129(26):1357-60. PubMed ID: 3292989
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.